Regeneron Pharmaceuticals News Timeline Breakdown

REGN -- USA Stock  

USD 366.45  0.22  0.06%

This is yet another view into Regeneron Pharmaceuticals filtered headlines to help investors concentrate on Regeneron Pharmaceuticals noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Regeneron Pharmaceuticals headlines in addition to utilizing other more conventional financial analysis modules. Additionally take a look at Regeneron Pharmaceuticals Backtesting and Regeneron Pharmaceuticals Hype Analysis.
Macroaxis News
July 27, 2018
Disposition of 50000 shares by Goldberg Murray A of Regeneron Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
Macroaxis News
July 30, 2018
Exercise or conversion by Alfred Gilman of 800 shares of Regeneron Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
Macroaxis News
August 2, 2018
Sale by Joseph Goldstein of 2000 shares of Regeneron Pharmaceuticals at MacroaxisInsider 
View Story
Macroaxis News
August 8, 2018
Exercise or conversion by Peter Powchik of 14625 shares of Regeneron Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
August 6, 2018
Experts Forecast Stem Cell Banking Market Positive Growth by 2018-2022 at thestockanalysis.com 
View Story
Thestreet News
August 1, 2018
Wondrous Stocks Marathon Patent Group, Inc. , Global Cord Blood Corporation , Sierra ... at www.thestreetpoint.com 
View Story
news
July 27, 2018
EPS for NantKwest, Inc. Expected At -0.38 Craft Brew Alliance, Inc. Had 0 Analysts Last Week at enbulletin.com 
View Story
Macroaxis News
August 3, 2018
Acquisition by Sonja Nelson of 40000 shares of NantKwest subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
August 10, 2018
Analyst Research and Recommendations NantKwest, Inc. , Acer Therapeutics Inc. at thewellesleysnews.com 
View Story
news
July 24, 2018
Nantkwest Inc CS Signal Update Ratings Review at dunlappost.com 
View Story
news
July 30, 2018
Dova Pharmaceuticals, Inc. Analysts See -0.58 EPS Quad Has 1.44 Sentiment at dminute.com 
View Story
news
August 2, 2018
Equity Research Analysts Stock Ratings Dova Pharmaceuticals, Inc. , Viasat, Inc. at thewellesleysnews.com 
View Story
news
August 9, 2018
Trilogy Global Advisors LP Has Decreased Its Nike Stake Shorts at Dova Pharmaceuticals Raised By ... at ztribune.com 
View Story
news
July 26, 2018
Digging Deeper Investors Taking a Second Look at Dova Pharmaceuticals, Inc. After Recent Market Moves at www.thecoinguild.com 
View Story
news
August 6, 2018
Set Sail With McEwen Mining Inc. , Auris Medical Holding AG at stocknewsgazette.com 
View Story
news
July 31, 2018
Investors Alert Gold Resource Corporation , Auris Medical Holding AG NASDAQEARS ... at www.stocksnewspoint.com 
View Story
seekingalpha News
July 31, 2018
Endocyte Is A Solid Buy Opportunity For 2018 at seekingalpha.com 
View Story
news
August 3, 2018
Are You Looking For Active Stock Endocyte, Inc. at nysedaily.com 
View Story
wired  News
August 7, 2018
A careful Technical Snap of Stock Endocyte, Inc. at nysewired.com 
View Story
news
July 25, 2018
Ra Capital Management Has Boosted Its Stake in Endocyte by 4.65 Million as Shares Rose As Jpmorgan ... at kreviewer.com 
View Story
wired  News
August 2, 2018
Stock Performance Summary Edge Therapeutics, Inc. at nysewired.com 
View Story
businessinsider News
August 8, 2018
Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress at markets.businessinsider.com 
View Story
news
July 30, 2018
FCF Scorecard Review For Edge Therapeutics, Inc. as FCF Growth Rolls to 1.000000 at cedarvillenews.com 
View Story

Did you try this?

Run Price Ceiling Movement Now
   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Price Ceiling Movement
Currently Active Assets on Macroaxis
S   
Purchased over 500 shares of
few days ago
Traded for 6.08
S   
Purchased over 500 shares of
few days ago
Traded for 6.08
MRN   
Purchased over 100 shares of
few days ago
Traded for 2.17
C   
Purchased over 40 shares of
few days ago
Traded for 71.99
F   
Purchased over 300 shares of
few days ago
Traded for 9.91
Additionally take a look at Regeneron Pharmaceuticals Backtesting and Regeneron Pharmaceuticals Hype Analysis. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.